‘Medicine Is Not a Stable Thing’: What We Heard This Week


“You’ve got to remember that medicine is not a stable thing.” — Dev GnanaDev, MD, former president of the Medical Board of California, discussing a bill that would grant the state’s licensing agencies specific authority to take disciplinary action against disinformation doctors.

“This is the American Medical Association, not the American Hunting Association or the American Gun Owners Association.” — Lonnie Bristow, MD, former AMA president, on an AMA resolution that called on candidates for public office to refuse contributions from any organization that opposes public health measures to reduce firearm violence.

“Softly open the door instead of bashing them over the head with risk assessments and numbers.” — Ciaran Considine, PhD, of Vanderbilt University Medical Center in Nashville, on preventing suicide among people with Huntington’s disease.

“This warning is still appropriate.” — Jessica Ailani, MD, of MedStar Georgetown University Hospital in Washington, D.C., regarding long-standing warnings to avoid triptans in migraine patients with known cardiovascular disease.

“We are always going to be behind the 8-ball.” — Eric Rubin, MD, PhD, of Brigham and Women’s Hospital in Boston, commenting on an FDA advisory committee’s reliance on outdated data when making decisions about the safety and efficacy of vaccines in the midst of a pandemic.

“It’s a myth.” — Lawrence Kleinman, MD, MPH, of Rutgers Robert Wood Johnson Medical School, on children being spared from the worst effects of COVID-19.

“Nowadays, we have commercials with Serena Williams talking about migraine but in the ’90s, we didn’t have that.” — Fred Cohen, MD, of Thomas Jefferson University in Philadelphia, discussing the rising prevalence of migraine disability.

“What we don’t want is to be kind of a green flag to say, ‘It’s open season for giving testosterone.'” — Channa Jayasena, PhD, of Imperial College London, on a meta-analysis showing testosterone treatment for male hypogonadism was safe for the heart.

“The virus is going to be able to continue to evolve to reinfect us at will.” — Amesh Adalja, MD, of the Johns Hopkins Center for Health Security in Baltimore, on new COVID-19 variants gaining foothold.

Products You May Like

Articles You May Like

POEM Trial Results Hold Firm for Long-Term Efficacy in Achalasia
Private Practice Pros; Unexplained Immunity; Cancer’s Heavy Toll
After promising data, experts say many questions remain over an experimental Alzheimer’s drug
Master of Medical Sciences in Clinical Investigation Program Overview
Science Matters with Andrew Kruse

Leave a Reply

Your email address will not be published.